Decreased survival in EGFR gene amplified vulvar carcinoma-Reference-Cited by-同舟云学术

Decreased survival in EGFR gene amplified vulvar carcinoma

Published:2008-11 Issue:2 Volume:111 Page:289-297
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Growdon Whitfield B.,Boisvert Susan L.,Akhavanfard Sara,Oliva Esther,Dias-Santagata Dora C.,Kojiro Sakiko,Horowitz Neil S.,Iafrate A. John,Borger Darrell R.,Rueda Bo R.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference49 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J. Clin.,2008

2. Carcinoma of the vulva;Stehman;Obstet. Gynecol.,2006

3. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States;Stroup;Gynecol. Oncol.,2008

4. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study;Maggino;Cancer,2000

5. EGFR antagonists in cancer treatment;Ciardiello;N. Engl. J. Med.,2008

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vulvar cancer management and wrangling recurrent disease: A report from the Society of Gynecologic Oncology journal club;Gynecologic Oncology Reports;2023-12

2. Current status of vulvar cancer in Japan: analysis of the Japanese Gynecologic Oncology Group nationwide survey study;Japanese Journal of Clinical Oncology;2023-08-07

3. European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023;International Journal of Gynecologic Cancer;2023-06-27

4. Prostaglandin E2 receptor EP1 expression in vulvar cancer;Journal of Cancer Research and Clinical Oncology;2022-11-27

5. Prostaglandin E2 receptor EP1 expression in vulvar cancer;2022-09-22